| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |